Department of Pain and Translational Symptom Science and Placebo Beyond Opinions Center, School of Nursing, University of Maryland, Baltimore, Maryland, USA; email:
Annu Rev Pharmacol Toxicol. 2024 Jan 23;64:171-190. doi: 10.1146/annurev-pharmtox-022723-112425. Epub 2023 Aug 16.
Adverse nocebo responses can cause harm to patients and interfere with treatment adherence and effects in both clinic practice and clinical trials. Nocebo responses refer to negative outcomes to active medical treatments in clinical trials or practice that cannot be explained by the treatment's pharmacologic effects. Negative expectancies and nocebo effects are less known than placebo responses. Nocebo effects can be triggered by verbal suggestions, prior negative experiences, observation of others experiencing negative outcomes, and other contextual and environmental factors. As research advances over the years, mechanistic knowledge is accumulating on the neurobiological mechanisms of nocebo effects. This review summarizes studies on different facets of nocebo effects and responses and discusses clinical implications, ethical considerations, and future directions.
不良反应的反安慰剂效应可能会对患者造成伤害,并干扰临床实践和临床试验中的治疗依从性和效果。反安慰剂效应是指在临床试验或实践中,活性药物治疗出现无法用药物药理作用解释的负面结果。与安慰剂反应相比,负面预期和反安慰剂效应的认知度较低。反安慰剂效应可由言语暗示、先前的负面经历、观察他人出现负面结果以及其他情境和环境因素引发。随着近年来研究的进展,反安慰剂效应的神经生物学机制的机制知识正在不断积累。本综述总结了关于反安慰剂效应和反应的不同方面的研究,并讨论了临床意义、伦理考虑和未来方向。